Canopy Growth Corporation (TSX: WEED)
Canada
· Delayed Price · Currency is CAD | Market Cap | 555.25M |
| Revenue (ttm) | 280.50M |
| Net Income (ttm) | -564.57M |
| Shares Out | 105.36M |
| EPS (ttm) | -6.67 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 770,971 |
| Open | 5.40 |
| Previous Close | 5.36 |
| Day's Range | 5.25 - 5.40 |
| 52-Week Range | 3.74 - 20.50 |
| Beta | 1.79 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2024 |
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products und... [Read more]
Financial Performance
In 2023, Canopy Growth's revenue was 297.15 million, a decrease of -10.83% compared to the previous year's 333.25 million. Losses were -657.27 million, -79.95% less than in 2022.
Financial StatementsNews
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy Growth Corporation ‘s (NASDAQ: CGC) strategy for capturing the U.S. cannabis market was the focal point of a recent fireside chat hosted by Zuanic & Associates . CEO David Klein and CFO Judy H...
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy Growth Corporation‘s CGC strategy for capturing the U.S. cannabis market was the focal point of a recent fireside chat hosted by Zuanic & Associates . CEO David Klein and CFO Judy Hong provided...
Canopy Growth, Aurora And Another Cannabis Giant Unveil Product Innovations, Here's What's New
Several major players in the cannabis industry are expanding their product offerings in Canada and the U.S. through new partnerships and innovative product launches. Canopy Growth Canopy Growth Corpor...
Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada
Canopy Growth brings the best of California's award winning Claybourne Pre-Roll Joint brand to adult-use consumers across Canada with the launch of 'Frosted Flyers' SMITHS FALLS, ON , Nov. 20, 2024 /P...
The Top Canadian Cannabis Stocks for November 2024 Growth
The cannabis industry continues to gain momentum in North America, with Canadian cannabis companies at the forefront of global expansion. As of 2023, the U.S. cannabis industry is projected to surpass...
Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY
Vertically integrated cannabis operator Acreage Holdings, Inc. (CSE: ACRG , ACRG.B.U)) (OTCQX: ACRHF , ACRDF)) reported its financial results Thursday for the third quarter ended Sept. 30, 2024. "In t...
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
If controversial Republican Matt Gaetz manages to win confirmation as attorney general, his tenure at the Justice Department is expected to be positive for the cannabis industry.
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Industry Trends
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Industry Trends
Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say
A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers in the industry, as optimism around the promise of a legal market has faded.
Canopy Growth (CGC) Q2 2025 Earnings Call Transcript
CGC earnings call for the period ending September 30, 2024.
Canopy Growth Corporation (CGC) Q2 2025 Earnings Call Transcript
Canopy Growth sees positive earnings ahead thanks to cost savings
Canopy Growth (CGC) stock will be on watch after its Q2 FY25 results as company projects positive adjusted EBITDA despite revenue decline. Read more here.
Canopy Growth Corp Q2 FY2025 Earnings: EPS Miss, Revenue Surpasses Estimates at $63 Million
Canopy Growth Corp Q2 FY2025 Earnings: EPS Miss, Revenue Surpasses Estimates at $63 Million
Earnings Snapshot: Canopy Growth FQ2 revenue falls, adjusted EBITDA loss narrows
Canopy Growth Reports Second Quarter Fiscal Year 2025 Financial Results
Storz & Bickel net revenue increased 32% year-over-year in Q2 FY2025 Continued growth across medical cannabis businesses, with net revenue increasing year-over-year by 16% in Canada and 12% in interna...
Canopy Growth (CGC) Stock Surges 5.2% Amid Industry Movement
Canopy Growth (CGC) Stock Surges 5.2% Amid Industry Movement
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Canopy Growth Q2 Earnings Preview: Revenue fall expected
Canopy Growth (CGC) Q2 earnings preview: Analysts expecting a loss of $0.24/share on revenue of $47.9M.
OSC tribunal tosses out illegal short-selling case against Cormark Securities
Watchdog failed to prove allegations that involved shares of cannabis company Canopy Growth
Canopy Growth's Earnings Outlook
Canopy Growth (NASDAQ: CGC) is set to give its latest quarterly earnings report on Friday, 2024-11-08. Here's what investors need to know before the announcement. Analysts estimate that Canopy Growth...
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Donald Trump's presidential election victory Tuesday, the cannabis sector took a sharp downturn.
Cannabis Stocks Plummet After Legalization Bid Fails in Florida
Shares of cannabis companies fell Wednesday after a ballot measure that would have legalized recreational marijuana in Florida failed to pass.
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
U.S.-focused cannabis stocks and ETFs may have taken a dip in pre-market trading on Wednesday in response to 2024 U.S. election outcomes . However, with earnings season gearing up it remains to be see...
Cannabis stocks crater as Florida fails to garner needed votes for adult use
North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure passed in Nebraska.
Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up
As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with proje...